MINNEAPOLIS, Feb. 29, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade imaging Real World Data (“iRWD”), today announced a partnership with a large-scale, multi-state healthcare system to advance the development of new diagnostic and treatment solutions using OneMedNet’s iRWD™. Pharmaceutical, AI, medical device, and clinical research organizations are increasingly leveraging the use of existing real world data across many stages of development from ideation up to and including post-market surveillance.
“Life science organizations have experienced tremendous benefit in utilizing RWD in their innovation process and go-to-market execution,” said Aaron Green, OneMedNet President. “The challenge they all face is getting access to diverse high quality data that is interpretable and flawlessly accurate. Importantly, we not only provide Life Science organizations with more accurate data, we also enable more accurate decision-making.”
This new partner has over 30 hospitals spread across 9 states and serves over 2 million people annually with noteworthy specialty clinics in the fields of Neurology, Orthopedics, Oncology and Cardiology. The addition of this organization has increased our partner network by approximately 15% and is accelerating our ability to provide the specific data our customers need. This allows OneMedNet to fulfill customer orders faster and more broadly than has been done in the past.
Often, life science innovators require data that is extremely specific with precise multi-variable and multi-level matching on a longitudinal scale. In order to meet these requirements, the RWD curating company must have a massive network and the ability to add new partners quickly. With OneMedNet’s indexing platform and unparalleled data curation team, OneMedNet is at the forefront in providing RWD, inclusive of imaging, to the market.
The OneMedNet iRWD™ network consists of over 235 healthcare systems and providers who not only provide state-of-the-art patient care today, but also want to be the transformational driver for impactful and measurable care improvements tomorrow.
About OneMedNet Corporation
Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing its proven OneMedNet iRWD™ solution, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements. For more information, please visit www.onemednet.com.
Investor Contact
Shannon Devine
MZ Group North America
203-741-8811
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$1.05 |
Daily Change: | 0.08 8.79 |
Daily Volume: | 135,744 |
Market Cap: | US$29.390M |
December 02, 2024 September 26, 2024 July 26, 2024 June 14, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB